A component of green tea can help deliver drugs to tumors in the body

August 8, 2018, Agency for Science, Technology and Research (A*STAR), Singapore
Credit: CC0 Public Domain

Wrapping an anticancer drug in a nanoscale case made of a polymer and a component of green tea is an extremely effective way to deliver high doses of the drug to tumors, an A*STAR team has shown. They demonstrated the system's potential by using it to inhibit the growth of liver tumors in mice.

The molecules of some polymers are water attracting (hydrophilic) on one end and water repellent (hydrophobic) on the other. When placed in water, such polymers form nanoscale balls known as micelles with their hydrophilic ends facing outward. These micelles make excellent vehicles for transporting drugs to a desired site in the body. That is because an insoluble drug can be stashed in the of the micelle, preventing it from harming other tissues until it is released at the tumor, while the hydrophilic outer surface enables the micelle to travel in the bloodstream. Micelles can be designed to target tumors through various mechanisms.

Although polymeric micelles have been well studied, in clinical trials they have generally failed to live up to expectations. Their poor performance was down to their low drug-loading capacity—often they can carry only about 10 per cent of their total weight—and their instability, which causes them to break up and offload their cargo before reaching a target, damaging healthy tissue.

Now, Motoichi Kurisawa at the A*STAR Institute of Bioengineering and Nanotechnology, and colleagues, have shown that micelles with hydrophilic tips made of the poly(ethylene glycol), commonly known as PEG, and hydrophobic tails of epigallocatechin gallate (EGCG)—a component of green tea—overcome both these problems. The researchers found that the micelles had a remarkably high drug-loading capacity of over 80 per cent for the doxorubicin. They were also stable in the bloodstream.

"We didn't expect such a high loading capacity," says Kurisawa. "Usually micelles become unstable as you increase their drug-loading capacity, and yet our micellar nanocomplexes are soluble in water. That came as a surprise both to us and to some of the reviewers of the paper, who asked us to check our work. But we confirmed the results."

The results also demonstrated the versatility of the micelles. "In a previous study, we utilized the protein antibody drug (see earlier highlight); this time, we used a small drug," says Kurisawa. "This is the advantage over existing systems: EGCG can interact with different types of drugs, including antibodies, proteins, small drugs and even nucleic acid. However, specific polymer carriers have to be designed to encapsulate specific drugs in conventional techniques."

In addition to being useful for transporting , EGCG is also known to be a powerful anti-oxidant with anti-cancer properties. The team is now exploring this synergism.

Explore further: Researchers develop green tea-based 'missiles' to kill cancer cells more effectively

More information: Kun Liang et al. Highly Augmented Drug Loading and Stability of Micellar Nanocomplexes Composed of Doxorubicin and Poly(ethylene glycol)-Green Tea Catechin Conjugate for Cancer Therapy, Advanced Materials (2018). DOI: 10.1002/adma.201706963

Related Stories

Researchers develop green tea-based 'missiles' to kill cancer cells more effectively

October 6, 2014
Green tea has long been known for its anti-oxidant, anti-cancer, anti-aging and anti-microbial properties. A group of researchers from the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR has taken the health ...

Recommended for you

Two ways cancer resists treatment are actually connected, with one activating the other

December 18, 2018
Drugs that target BRAF and MEK in cancer have shown promise in treating a subset of melanoma that carries a mutation in the BRAF gene, but drug resistance usually emerges, reversing the benefit of these drugs and limiting ...

HPV discovery raises hope for new cervical cancer treatments

December 18, 2018
Researchers at the University of Virginia School of Medicine have made a discovery about human papillomavirus (HPV) that could lead to new treatments for cervical cancer and other cancers caused by the virus.

Vaccine, checkpoint drugs combination shows promise for pancreatic cancers

December 18, 2018
Researchers at the Johns Hopkins Kimmel Cancer Center discovered a combination of a cancer vaccine with two checkpoint drugs reduced pancreatic cancer tumors in mice, demonstrating a possible pathway for treatment of people ...

Researchers identify ways breast cancer avoids immune system detection

December 18, 2018
Recent breakthroughs in immunotherapy are making a huge difference in treating some forms of cancer, especially metastatic cancer. But breast cancer has proven a tricky foe for this new therapy, and an interdisciplinary team ...

Metal chemotherapy drugs boost the impact of immunotherapy in cancer

December 18, 2018
Due to their powerful tumour-killing effect, metal-based chemotherapies are frequently used in cancer treatment. However, it was hitherto assumed that they damaged the immune system, because of their cytotoxic (cell-damaging) ...

10-year follow-up after negative colonoscopies linked to lower colorectal cancer risk

December 17, 2018
Ten years after a negative colonoscopy, Kaiser Permanente members had 46 percent lower risk of being diagnosed with and were 88 percent less likely to die from colorectal cancer compared with those who did not undergo colorectal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.